U.S. Markets open in 2 hrs 34 mins

Weekly CEO Buys Highlight

- By Joy Hu

According to GuruFocus Insider Data, these are the largest CEO buys from the past week.

New Fortress Energy CEO bought 2,500,000 shares

New Fortress Energy LLC (NFE) CEO Wesley R. Edens bought 2,500,000 shares on Feb. 4 for an average price of $14 per share. The stock price has not changed significantly since then.


The energy infrastructure company delivers energy solutions to customers so they can use natural gas for power. The company has a market cap of $2.34 billion. Its shares were trading at $14 on Feb. 8.

On Jan. 30, the company announced the pricing of its initial public offering of 20,000,000 Class A shares at $14 per share.

Director C. William Griffin bought 64,039 shares on Feb. 4 at a price of $13.79 and 35,961 shares on Feb. 5 at a price of $13.97. Since then, the share price has increased 0.21%. Director and 10% owner Randal A. Nardone bought 2,500,000 shares on Feb. 4 for $14 per share.

WisdomTree Investments CEO bought 85,000 shares

WisdomTree Investments Inc. (WETF) CEO Jonathan L. Steinberg bought 85,000 shares on Feb. 4 for an average price of $5.98 per share.

WisdomTree is an exchange-traded fund and exchange-traded product sponsor and asset manager. It offers equity ETFs, international hedged equity ETFs, currency ETFs and fixed income ETFs. The company has a market cap of $901.85 million. Its shares traded at $5.97 per share with a price-earnings ratio of 25.96 as of Feb. 8.

Net loss for the fourth quarter of 2018 was $11.6 million compared to net income of $0.2 million for the prior-year period.

Chief Financial Officer Amit Muni bought 13,500 shares on Feb. 4 for $5.99 per share. Chief Administrative Officer Peter M. Ziemba bought 16,000 shares for $6.07 per share. Director Anthony Bossone bought 50,000 shares for $5.92.

Zimmer Biomet Holdings CEO bought 2,100 shares

Bryan C. Hanson, president and CEO of Zimmer Biomet Holdings Inc. (ZBH), bought 2,100 shares on Feb. 7 for an average price of $119.02 per share. Since then, the share price has risen 1.31%.

Zimmer Biomet is a medical device company. It designs, manufactures and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. The company has a market cap of $24.60 billion. Its shares traded at $120.58 as of Feb. 8.

Net loss for the fourth quarter of 2018 was $902.5 million compared to net earnings of $1.231 billion for the prior-year period.

Director Maria Teresa Hilado bought 1,650 shares on Feb. 7 for $118.18 per share. The share price has increased by 2.03% since then.

Director Christopher B. Begley bought 2,540 shares on Feb. 6 for an average price of $117.19 per share. The price of the stock has increased by 2.89% since then. Director Betsy J. Bernard bought 4,250 shares on Feb. 6 at a price of $117.41 per share. Since then, price has increased 2.7%.

Director Gail Boudreaux bought 2,095 shares on Feb. 5 for $119.33 per share. The share price has increased 1.05% since then. Director Robert Hagemann bought 2,000 shares on Feb. 5 for $119.83 per share. The share price has risen 0.63% since then.

FS KKR Capital CEO bought 31,352 shares

FS KKR Capital Corp. (FSK) CEO Michael C. Forman bought 31,352 shares during the past week for an average price of $6.35 per share.

The business development company focuses on providing customized credit solutions to private middle-market U.S. companies. The company has a market cap of $3.29 billion. Its shares traded at $6.19 as of Feb. 8.

On Dec. 19, the company announced the closing of the merger of FS Investment Corp. and Corporate Capital Trust Inc.

Forman bought 25,689 shares on Jan. 29 for $6.27 per share; 29,188 shares on Jan. 25 for $6.23 per share; 15,925 shares on Jan. 31 for $6.35 per share; 15,679 shares on Feb. 4 for $6.35 per share; and 15,673 shares on Feb. 6 for $6.35 per share. The share price has decreased 2.52% since then.

Director Richard I. Goldstein bought 5,000 shares on Jan. 17 for an average price of $5.85 per share and 3,800 shares on Jan. 22 for $6.07. The share price has increased 1.98% since then.

Chief Investment Officer Daniel Pietrzak bought 50,000 shares on Jan. 17 for $5.88 per share. The share price has climbed 5.27% since then.

Bain Capital Specialty Finance CEO bought 2,409 shares

Bain Capital Specialty Finance Inc. (BCSF) President and CEO Michael A. Ewald bought 2,409 shares during the past week for an average price of $19.60 per share.

The business development company utilizes Bain Capital Credit's Private Credit Group to focus on middle-market investments. The company has a market cap of $1.01 billion. Its shares traded at $19.62 with a price-earnings ratio of 13.99 as of Feb. 8.

On Nov. 14, the company announced it priced its initial public offering of 7,500,000 shares at $20.25 per share.

Ewald bought 1,239 shares on Feb. 7 for $19.55 per share and 1,170 shares on Feb. 8 for $19.65 per share. The share price has decreased 0.15% since then.

Vice President and Treasurer Michael John Boyle bought 494 shares on Feb. 7 at a price of $19.55 and 468 shares on Feb. 8 at a price of $19.65. Since then, the share price has decreased by 0.15%.

Director Jeffrey B. Hawkins bought 1,239 shares on Feb. 7 at a price of $19.55 and 1,170 shares on Feb. 8 at a price of $19.65. The share price has dipped 0.15% since then.

For the complete list of stocks bought by company CEOs, go to CEO Buys.

Disclosure: I do not own shares of any of the companies mentioned.

This article first appeared on GuruFocus.